Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacological profile of dextrorphan

A Fossati1, M G Vimercati, R Caputo

  • 1Department of Pharmacology, Farmaceutici Formenti S.p.A., Research Centre, Origgio, VA, Italy.

Arzneimittel-Forschung
|November 1, 1995
PubMed
Summary

Dextrorphan, the active form of dextromethorphan, shows similar cough-suppressing effects but with improved safety and lower toxicity. These findings support using dextrorphan over dextromethorphan in medical treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychosocial functional recovery in patients with bipolar disorder in remission: Which symptoms hold them back?

Journal of affective disorders·2026
Same author

Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study).

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Unravelling the Link Between Body Mass Index and Cognitive Performance in Individuals With Bipolar Disorder and Exploration of PRS Moderation Effect: Findings From the PsyCourse Study.

Acta psychiatrica Scandinavica·2025
Same author

Effectiveness of Biologic Therapy in Hidradenitis Suppurativa: Real-World Clinical Outcomes and Lipid Profile Evaluation.

The Australasian journal of dermatology·2025
Same author

Arrhythmias and other cardiovascular diseases in young patients (<40 years) with moderate/severe atopic dermatitis: A multicentric study in northern Italy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case-series.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Area of Science:

  • Pharmacology
  • Toxicology
  • Medicinal Chemistry

Background:

  • Dextromethorphan is a widely used antitussive agent.
  • Dextrorphan is the primary active metabolite of dextromethorphan.
  • Understanding the comparative pharmacology and toxicity is crucial for therapeutic optimization.

Purpose of the Study:

  • To compare the antitussive activity, central nervous system pharmacology, and acute toxicity of dextrorphan and dextromethorphan.
  • To evaluate the therapeutic potential of dextrorphan relative to its precursor.

Main Methods:

  • Pharmacological studies assessing antitussive effects.
  • Toxicological evaluations of acute toxicity.
  • Comparative analysis of central nervous system effects.

Related Experiment Videos

Main Results:

  • Dextrorphan demonstrated comparable antitussive activity to dextromethorphan.
  • Dextrorphan exhibited better tolerability than dextromethorphan.
  • Dextrorphan showed a lower toxicity profile compared to dextromethorphan.

Conclusions:

  • Dextrorphan possesses a favorable therapeutic index over dextromethorphan.
  • The findings suggest dextrorphan as a potentially superior alternative for antitussive therapy.
  • Further clinical investigation into dextrorphan for cough suppression is warranted.